Vasohibin‐2 is required for epithelial–mesenchymal transition of ovarian cancer cells by modulating transforming growth factor‐β signaling
Rie Iida‐Norita(Tohoku University), Yasufumi Sato(Tohoku University)
Cited by 34
Related Papers
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis
|Journal of Clinical Investigation|2004|287
Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis
|Journal of Clinical Investigation|2004|263
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody
|Cancer Medicine|2021|13
Development of a Novel and Simple Anti-Metastatic Cancer Treatment Targeting Vasohibin-2
|The Tohoku Journal of Experimental Medicine|2023|3